Clinical Trials in San Francisco

Showing 4041-4060 of 12,991 trials

Biomarkers to Predict Time to Plasma HIV RNA Rebound

NCT03001128

The purpose of this study is to collect information about what happens when people pause, or temporarily stop taking, ART, and to collect blood samples from these people at frequent intervals. We will also study the safety of pausing ART under close observation.

HIV-1 Infection

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections61 participantsStarted Feb 2017

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +15 more locations

TERMINATEDPhase 3< 1 mile

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

NCT04322682

This is a phase 3, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection and have at least one high-risk criterion. Approximately 6000 subjects meeting all inclusion and no exclusion criteria will be randomized to receive either colchicine or placebo tablets for 30 days.

Corona Virus Infection

Montreal Heart Institute4,506 participantsStarted Mar 2020

Phoenix, Arizona, United States • Yuma, Arizona, United States • Bakersfield, California, United States +29 more locations

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

Find Trials by Condition in San Francisco

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

In Vivo Pulse Oximeter Validation Study

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Topical Treatment for TMJ Arthralgia

A Study of Adolescents Undergoing a Mindfulness Training During COVID-19

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

SpineJack System Postmarket Registry

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Osia 2 Pediatric Expansion Study

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer